Pages that link to "Q36216295"
Jump to navigation
Jump to search
The following pages link to Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels. (Q36216295):
Displaying 39 items.
- A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. (Q24301857) (← links)
- Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death (Q24315099) (← links)
- The channelopathies: novel insights into molecular and genetic mechanisms of human disease (Q24532317) (← links)
- Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia (Q33159040) (← links)
- Genetic testing of inherited arrhythmias. (Q33161113) (← links)
- Localization of an NH(2)-terminal disease-causing mutation hot spot to the "clamp" region in the three-dimensional structure of the cardiac ryanodine receptor (Q33565617) (← links)
- Ryanodine receptor channelopathies (Q33912937) (← links)
- Inositol trisphosphate receptor Ca2+ release channels. (Q33983069) (← links)
- Cardiac ryanodine receptor phosphorylation: target sites and functional consequences (Q33995185) (← links)
- In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation (Q34313368) (← links)
- Localization of the dantrolene-binding sequence near the FK506-binding protein-binding site in the three-dimensional structure of the ryanodine receptor (Q34752142) (← links)
- Malignant hyperthermia: a pharmacogenetic disorder (Q34883560) (← links)
- Chain-reaction Ca(2+) signaling in the heart (Q35865391) (← links)
- Stressed out: the skeletal muscle ryanodine receptor as a target of stress (Q36407033) (← links)
- From molecule to malady (Q36428969) (← links)
- Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies (Q36642953) (← links)
- Altered cardiac myocyte Ca regulation in heart failure. (Q36659965) (← links)
- Regulation of Ca2+ and Na+ in normal and failing cardiac myocytes (Q36667318) (← links)
- Ryanodine receptors, calcium signaling, and regulation of vascular tone in the cerebral parenchymal microcirculation. (Q36729418) (← links)
- In situ calcium signaling: no calcium sparks detected in rat myometrium (Q36736966) (← links)
- Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia (Q36853107) (← links)
- Ryanodine receptor-mediated arrhythmias and sudden cardiac death. (Q37248371) (← links)
- A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses. (Q37305886) (← links)
- Ryanodine receptor and calsequestrin in arrhythmogenesis: what we have learnt from genetic diseases and transgenic mice (Q37332464) (← links)
- The role of genetic testing in paediatric syndromes of sudden death: state of the art and future considerations (Q37621582) (← links)
- Cardiac Channelopathies and Sudden Death: Recent Clinical and Genetic Advances (Q37728178) (← links)
- Channelopathies linked to plasma membrane phosphoinositides. (Q37732004) (← links)
- Characterization of Ca(2+)-Dependent Protein-Protein Interactions within the Ca(2+) Release Units of Cardiac Sarcoplasmic Reticulum (Q38541159) (← links)
- Murine Electrophysiological Models of Cardiac Arrhythmogenesis (Q39038606) (← links)
- Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia (Q39978369) (← links)
- Modulation of SR Ca2+ release by the triadin-to-calsequestrin ratio in ventricular myocytes (Q42503629) (← links)
- Electron microscopy of ryanodine receptors (Q42721067) (← links)
- A novel ryanodine receptor mutation linked to sudden death increases sensitivity to cytosolic calcium. (Q43118021) (← links)
- Reduced threshold for store overload-induced Ca2+ release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease (Q49577286) (← links)
- Diversification of the muscle proteome through alternative splicing. (Q52671372) (← links)
- Early administration of nifedipine protects against angiotensin II-induced cardiomyocyte hypertrophy through regulating CaMKII-SERCA2a pathway and apoptosis in rat cardiomyocytes. (Q52881074) (← links)
- Brugada Syndrome Unmasked by Accidental Inhalation of Gasoline Vapors (Q57805930) (← links)
- Ryanodinopathies: RyR-Linked Muscle Diseases (Q83483025) (← links)
- CPVT: Arrhythmogenesis, Therapeutic Management, and Future Perspectives. A Brief Review of the Literature (Q92409590) (← links)